שימוש בתרכובות ctla4 להשגת נסיגה ללא תרופה בנבדקים עם ra מוקדם

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

申请号：

IL24842116

公开号：

IL248421D0

申请日:

2016.10.20

申请国别(地区):

IL

年份:

2016

代理人:

摘要：

The present invention is directed to methods and compositions for achieving drug-free remission in subjects with early RA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule until Disease Activity Score Calculator for Rheumatoid Arthritis (DAS)-defined remission is achieved and then withdrawing the RA therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/